Ramana Reddy Kankanala, MD
Family Medicine · Springfield, MONPI 1679756381
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 177 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 14.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,586 and has fallen 99.0% since, to $16 in 2025.
Across 177 payments — averaging $13.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$351
- Novo Nordisk$279
- Amgen$277
- Sanofi-aventis U.S. LLC$254
- Boehringer Ingelheim$225
- Abbott$220
- plus $857 from 20 others
What the payments were for
- Food & beverage$2,455100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 25 | $351 |
| Novo Nordisk | 22 | $279 |
| Amgen | 19 | $277 |
| Sanofi-aventis U.S. LLC | 22 | $254 |
| Boehringer Ingelheim | 17 | $225 |
| Abbott | 13 | $220 |
| AstraZeneca | 13 | $201 |
| Johnson & Johnson | 7 | $87 |
| Antares Pharma, Inc. | 5 | $67 |
| Dexcom, Inc. | 5 | $61 |
| Merck | 3 | $43 |
| AbbVie | 3 | $41 |
| Amarin Pharma, Inc. | 2 | $40 |
| Exact Sciences | 2 | $40 |
| Lilly USA, LLC | 3 | $37 |
| Radius Health, Inc. | 2 | $36 |
| Shire North American Group Inc | 3 | $35 |
| Medtronic | 2 | $30 |
| Valeritas, Inc. | 2 | $30 |
| Braeburn Inc. | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Bayer | 1 | $17 |
| GSK | 1 | $17 |
| Alfasigma USA, Inc. | 1 | $13 |
| Aegerion Pharmaceuticals, Inc. | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
How this compares
$2,462 in reported general payments places this provider in the 75th percentile of 2,203 family medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 80 | $17,548 |
| Buprenorphine Hcl | 79 | $4,387 |
| Buprenorphine | 14 | $1,765 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 49 | $1,180 |
| Gabapentin | 40 | $465 |
| Oxycodone Hcl | 32 | $459 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 24 | $456 |
| Lisinopril | 27 | $318 |
| Morphine Sulfate ErMorphine Sulfate | 22 | $301 |
| Atorvastatin Calcium | 37 | $297 |
| Tramadol Hcl | 30 | $278 |
| Morphine Sulfate | 19 | $249 |
| Levothyroxine Sodium | 30 | $237 |
| Metoprolol Succinate | 11 | $185 |
| Mirtazapine | 15 | $159 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Springfield
- Stephen AdamsSpringfield$636K
- Roger CadySpringfield$175K
- Don BrockmanSpringfield$31K
- James van RiessenSpringfield$25K
- Justin PuckettKirksville$568K
- Matthew BeckerditeOfallon$225K
- James LasalleExcelsior Springs$130K
- Matthew TiefenbrunnSullivan$105K
- Ayobami OduwoleGrandview$92K
- Michael DonovanSaint Louis$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.